65 related articles for article (PubMed ID: 12447905)
1. Structurally adaptive hot spots at a protein interaction interface on TRAF3.
Ely KR; Li C
J Mol Recognit; 2002; 15(5):286-90. PubMed ID: 12447905
[TBL] [Abstract][Full Text] [Related]
2. Binding sites of cytoplasmic effectors TRAF1, 2, and 3 on CD30 and other members of the TNF receptor superfamily.
Boucher LM; Marengère LE; Lu Y; Thukral S; Mak TW
Biochem Biophys Res Commun; 1997 Apr; 233(3):592-600. PubMed ID: 9168896
[TBL] [Abstract][Full Text] [Related]
3. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.
Hauer J; Püschner S; Ramakrishnan P; Simon U; Bongers M; Federle C; Engelmann H
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2874-9. PubMed ID: 15708970
[TBL] [Abstract][Full Text] [Related]
4. Downstream regulator TANK binds to the CD40 recognition site on TRAF3.
Li C; Ni CZ; Havert ML; Cabezas E; He J; Kaiser D; Reed JC; Satterthwait AC; Cheng G; Ely KR
Structure; 2002 Mar; 10(3):403-11. PubMed ID: 12005438
[TBL] [Abstract][Full Text] [Related]
5. Prediction of the interaction site on the surface of an isolated protein structure by analysis of side chain energy scores.
Liang S; Zhang J; Zhang S; Guo H
Proteins; 2004 Nov; 57(3):548-57. PubMed ID: 15382230
[TBL] [Abstract][Full Text] [Related]
6. Structure-function relationship of tumor necrosis factor (TNF) and its receptor interaction based on 3D structural analysis of a fully active TNFR1-selective TNF mutant.
Mukai Y; Shibata H; Nakamura T; Yoshioka Y; Abe Y; Nomura T; Taniai M; Ohta T; Ikemizu S; Nakagawa S; Tsunoda S; Kamada H; Yamagata Y; Tsutsumi Y
J Mol Biol; 2009 Jan; 385(4):1221-9. PubMed ID: 19084540
[TBL] [Abstract][Full Text] [Related]
7. Protein-protein interactions in TRAF3.
Ely KR; Kodandapani R; Wu S
Adv Exp Med Biol; 2007; 597():114-21. PubMed ID: 17633021
[TBL] [Abstract][Full Text] [Related]
8. Key molecular contacts promote recognition of the BAFF receptor by TNF receptor-associated factor 3: implications for intracellular signaling regulation.
Ni CZ; Oganesyan G; Welsh K; Zhu X; Reed JC; Satterthwait AC; Cheng G; Ely KR
J Immunol; 2004 Dec; 173(12):7394-400. PubMed ID: 15585864
[TBL] [Abstract][Full Text] [Related]
9. TNFR signaling: ubiquitin-conjugated TRAFfic signals control stop-and-go for MAPK signaling complexes.
Karin M; Gallagher E
Immunol Rev; 2009 Mar; 228(1):225-40. PubMed ID: 19290931
[TBL] [Abstract][Full Text] [Related]
10. TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells.
Guo F; Sun A; Wang W; He J; Hou J; Zhou P; Chen Z
Mol Immunol; 2009 Aug; 46(13):2441-8. PubMed ID: 19540595
[TBL] [Abstract][Full Text] [Related]
11. Specific locations of hydrophilic amino acids in constructed transmembrane ligands of the platelet-derived growth factor beta receptor.
Freeman-Cook LL; Edwards AP; Dixon AM; Yates KE; Ely L; Engelman DM; Dimaio D
J Mol Biol; 2005 Jan; 345(4):907-21. PubMed ID: 15588835
[TBL] [Abstract][Full Text] [Related]
12. Protein-protein interactions: hot spots and structurally conserved residues often locate in complemented pockets that pre-organized in the unbound states: implications for docking.
Li X; Keskin O; Ma B; Nussinov R; Liang J
J Mol Biol; 2004 Nov; 344(3):781-95. PubMed ID: 15533445
[TBL] [Abstract][Full Text] [Related]
13. Hot regions in protein--protein interactions: the organization and contribution of structurally conserved hot spot residues.
Keskin O; Ma B; Nussinov R
J Mol Biol; 2005 Feb; 345(5):1281-94. PubMed ID: 15644221
[TBL] [Abstract][Full Text] [Related]
14. TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor.
Gardam S; Sierro F; Basten A; Mackay F; Brink R
Immunity; 2008 Mar; 28(3):391-401. PubMed ID: 18313334
[TBL] [Abstract][Full Text] [Related]
15. Hot spots--a review of the protein-protein interface determinant amino-acid residues.
Moreira IS; Fernandes PA; Ramos MJ
Proteins; 2007 Sep; 68(4):803-12. PubMed ID: 17546660
[TBL] [Abstract][Full Text] [Related]
16. The TNF receptor, RELT, binds SPAK and uses it to mediate p38 and JNK activation.
Polek TC; Talpaz M; Spivak-Kroizman T
Biochem Biophys Res Commun; 2006 Apr; 343(1):125-34. PubMed ID: 16530727
[TBL] [Abstract][Full Text] [Related]
17. Protein-protein interactions; coupling of structurally conserved residues and of hot spots across interfaces. Implications for docking.
Halperin I; Wolfson H; Nussinov R
Structure; 2004 Jun; 12(6):1027-38. PubMed ID: 15274922
[TBL] [Abstract][Full Text] [Related]
18. TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology.
Wu H; Arron JR
Bioessays; 2003 Nov; 25(11):1096-105. PubMed ID: 14579250
[TBL] [Abstract][Full Text] [Related]
19. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma.
Jackson-Bernitsas DG; Ichikawa H; Takada Y; Myers JN; Lin XL; Darnay BG; Chaturvedi MM; Aggarwal BB
Oncogene; 2007 Mar; 26(10):1385-97. PubMed ID: 16953224
[TBL] [Abstract][Full Text] [Related]
20. Structurally distinct recognition motifs in lymphotoxin-beta receptor and CD40 for tumor necrosis factor receptor-associated factor (TRAF)-mediated signaling.
Li C; Norris PS; Ni CZ; Havert ML; Chiong EM; Tran BR; Cabezas E; Reed JC; Satterthwait AC; Ware CF; Ely KR
J Biol Chem; 2003 Dec; 278(50):50523-9. PubMed ID: 14517219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
